10-Q · August 11, 2026
Anterix delivered a mixed quarter: diluted EPS of $0.01 exceeded the $(0.25) consensus estimate, while $1.958 million of revenue missed consensus by $19,200. Operating cash flow improved by $5.185 million year over year…
10-Q · Filed November 10, 2026 · Our reading of the company's report
The latest report
Second-quarter revenue was $1.958 million and diluted EPS was negative $0.25, with results benefiting from a $6.1 million gain on the exchange of broadband licenses. Contracted proceeds totaled $33.1 million, but…
Second-quarter revenue was $1.958 million and diluted EPS was negative $0.25, with results benefiting from a $6.1 million gain on the exchange of broadband licenses. Contracted proceeds totaled $33.1 million, but operating cash flow was negative $6.142 million and spectrum-clearing costs were $5.4 million. The company provided no quantitative forward guidance, and it disclosed no material changes to previously reported risk factors.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Second-quarter revenue was $1.958 million, while diluted EPS was a loss of $0.25 per share.
Results included a $6.1 million gain on the exchange of broadband licenses, which supported reported earnings.
The company reported $33.1 million of contracted proceeds, supporting future commercialization potential.
Management reported that disclosure controls and internal control over financial reporting were effective as of September 30, 2026, with no material changes during the period.
The board authorized a new $250.0 million share repurchase program effective September 22, 2026, extending through September 22, 2029.
Operating cash flow was negative $6.142 million for the quarter, indicating continued cash consumption despite the $6.1 million license-exchange gain.
Spectrum-clearing costs were $5.4 million, creating a material near-term cash requirement and execution risk for the company’s commercialization plans.
The filing states that inflation has increased certain operating expenses and could adversely affect customers and commercialization. A 10% change in market interest rates is not expected to materially affect results, but continued inflation could materially affect operating results and financial condition.
No quantitative forward revenue or EPS guidance was provided in the filing; outlook was deferred to the earnings release or call.
Anterix delivered a mixed quarter: diluted EPS of $0.01 exceeded the $(0.25) consensus estimate, while $1.958 million of revenue missed consensus by $19,200. Operating cash flow improved by $5.185 million year over year…
Anterix Inc. demonstrated strong financial recovery in FY2026, with net income reaching $90.6 million, an increase of 897% from a loss of $11.4 million in FY2025. The company successfully executed revenue growth of 8%…
Totals from the last full session. Insider and politician figures cover 90 days.
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
The free pages stop at the last full session. Trader shows every trade as it prints.